Cancer Research UK has more than 30 partnered agents in pre-clinical and clinical development, three drugs in phase 2/3 trials and eight drugs already on the market and benefiting patients.
Commercial Partnerships
Cancer Research UK has more than 30 partnered agents in pre-clinical and clinical development, three drugs in phase 2/3 trials and eight drugs already on the market and benefiting patients.
Click on the image to view our Clinical Development Partnerships (CDP) pipeline.
Click on the image to view our Clinical Development Partnerships (CDP) pipeline.